Atea Pharmaceuticals, Inc. (AVIR) vs Canopy Growth Corporation (CGC)
A side-by-side comparison of Atea Pharmaceuticals, Inc. and Canopy Growth Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVIR
Atea Pharmaceuticals, Inc.
$5.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CGC
Canopy Growth Corporation
$0.88HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AVIR vs CGC
growth of $100 · dividends reinvested · last 6yAVIR -83.1% (-25.6%/yr)CGC -99.5% (-59.1%/yr)AVIR compounded faster over this window
Log scale — wide-divergence pair
AVIR CGC
AVIR vs CGC: by the numbers
- •AVIR is the larger company ($411M vs $373M market cap).
- •Both run net losses; AVIR's is the smaller (0.00% vs -81.04% net margin).
Metrics side by side
Valuation
| Metric | AVIR | CGC |
|---|---|---|
| P/S ratio | N/A | 1.62 |
| P/B ratio | 2.01 | 0.77 |
Profitability
| Metric | AVIR | CGC |
|---|---|---|
| Gross margin | 0.00% | 25.47% |
| Operating margin | 0.00% | -31.98% |
| Net margin | 0.00% | -81.04% |
| ROE | -80.96% | -38.57% |
| ROIC | -89.93% | -10.85% |
Growth (annualized)
| Metric | AVIR | CGC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -12.47% |
| Total return CAGR (5Y) | -34.44% | -63.36% |
Frequently asked
- How have AVIR and CGC total returns compared?
- Over the past 5 years, AVIR delivered -34.44% and CGC delivered -63.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.